Exosomes as Regenerative Therapeutics in Non-Scarring Alopecia: Current Perspectives and Future Directions

Exosome-based therapy is emerging as a promising regenerative treatment for non-scarring alopecias like androgenetic alopecia and alopecia areata, offering a potentially standardizable and scalable alternative to conventional treatments. Exosomes, which are nanosized extracellular vesicles, enhance hair regeneration by modulating the hair follicle microenvironment through mechanisms such as Wnt/β-catenin signaling activation and angiogenesis promotion. Preclinical studies show strong follicular regeneration, and early clinical trials report improvements in hair density and thickness with favorable safety profiles. Despite these promising results, challenges remain in standardizing isolation methods, dosing, and delivery, as well as reducing production costs. High-quality clinical trials are necessary to facilitate the clinical translation of exosome therapies.